ASX - By Stock
|
ATH |
Value of company post Positive phase 2 trial results
|
|
pierre77
|
5 |
2.1K |
3 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
5
|
2.1K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
pierre77
|
169 |
48K |
12 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
169
|
48K
|
12
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
pierre77
|
169 |
48K |
11 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
169
|
48K
|
11
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
pierre77
|
169 |
48K |
13 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
169
|
48K
|
13
|
|
ASX - By Stock
|
ATH |
Re:
New all time low is looming
|
|
pierre77
|
33 |
12K |
2 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
33
|
12K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
The Fund started to post news
|
|
pierre77
|
8 |
2.9K |
1 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
8
|
2.9K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Molecular iron related mechanisms in AD and drug targets
|
|
pierre77
|
2 |
1.0K |
1 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
2
|
1.0K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Proposed issue of securities - ATH
|
|
pierre77
|
24 |
9.7K |
5 |
25/09/22 |
25/09/22 |
ASX - By Stock
|
24
|
9.7K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Alzheimers drug controversy
|
|
pierre77
|
4 |
1.3K |
4 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
4
|
1.3K
|
4
|
|
ASX - By Stock
|
ATH |
Alzheimers drug controversy
|
|
pierre77
|
4 |
1.3K |
5 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
4
|
1.3K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Today's Endpoints News Lead Article Regarding Eli Lilly Actions and Plans
|
|
pierre77
|
27 |
9.4K |
4 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
27
|
9.4K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
NEW PAPER about ATH434 and endothelial cells !!!!
|
|
pierre77
|
19 |
6.5K |
3 |
07/09/21 |
07/09/21 |
ASX - By Stock
|
19
|
6.5K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
NEW PAPER about ATH434 and endothelial cells !!!!
|
|
pierre77
|
19 |
6.5K |
4 |
06/09/21 |
06/09/21 |
ASX - By Stock
|
19
|
6.5K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Today's Endpoints News Lead Article Regarding Eli Lilly Actions and Plans
|
|
pierre77
|
27 |
9.4K |
0 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
27
|
9.4K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Lactoferrin as the key predictor of amyloid pathology
|
|
pierre77
|
3 |
1.4K |
2 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
3
|
1.4K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Lactoferrin as the key predictor of amyloid pathology
|
|
pierre77
|
3 |
1.4K |
2 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
3
|
1.4K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Lifespan and ath434
|
|
pierre77
|
10 |
4.6K |
5 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
10
|
4.6K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Lifespan and ath434
|
|
pierre77
|
10 |
4.6K |
3 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
10
|
4.6K
|
3
|
|
ASX - By Stock
|
ATH |
Lifespan and ath434
|
|
pierre77
|
10 |
4.6K |
10 |
09/08/21 |
09/08/21 |
ASX - By Stock
|
10
|
4.6K
|
10
|
|
ASX - By Stock
|
ATH |
Ath434 reversal of GI complications
|
|
pierre77
|
1 |
771 |
11 |
09/08/21 |
09/08/21 |
ASX - By Stock
|
1
|
771
|
11
|
|
ASX - By Stock
|
ATH |
Re:
Continuous Decline, New Lows
|
|
pierre77
|
9 |
3.6K |
4 |
21/07/21 |
21/07/21 |
ASX - By Stock
|
9
|
3.6K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New Publication Demonstrates ATH434 is Neuroprotective
|
|
pierre77
|
16 |
6.9K |
6 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
16
|
6.9K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Change in substantial holding
|
|
pierre77
|
12 |
4.3K |
4 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
12
|
4.3K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New US patent targeting major neurodegenerative diseases
|
|
pierre77
|
11 |
4.8K |
6 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
11
|
4.8K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
The Real Price
|
|
pierre77
|
63 |
25K |
8 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
63
|
25K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Antibiotic resistance fund aims 2-4 new antibiotics by 2030
|
|
pierre77
|
10 |
3.3K |
0 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
10
|
3.3K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New US patent targeting major neurodegenerative diseases
|
|
pierre77
|
11 |
4.8K |
7 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
11
|
4.8K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New US patent targeting major neurodegenerative diseases
|
|
pierre77
|
11 |
4.8K |
5 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
11
|
4.8K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New US patent targeting major neurodegenerative diseases
|
|
pierre77
|
11 |
4.8K |
4 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
11
|
4.8K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Looks like small cap biotech ADR's are hot right now in the US market
|
|
pierre77
|
3 |
1.8K |
3 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
3
|
1.8K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Any news ??, up in NY 8%
|
|
pierre77
|
26 |
10K |
0 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
26
|
10K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Any news ??, up in NY 8%
|
|
pierre77
|
26 |
10K |
2 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
26
|
10K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Covid-19 / hospital-acquired infections / multi drug resistance
|
|
pierre77
|
3 |
1.8K |
5 |
09/05/21 |
09/05/21 |
ASX - By Stock
|
3
|
1.8K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 3G
|
|
pierre77
|
9 |
3.0K |
4 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
9
|
3.0K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Antibiotic resistance market now 8 billions
|
|
pierre77
|
7 |
2.6K |
3 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
7
|
2.6K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to present at Global Life Science Conference
|
|
pierre77
|
5 |
2.6K |
2 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
5
|
2.6K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Research AD biomarkers to routine diagnostics
|
|
pierre77
|
6 |
2.8K |
5 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
6
|
2.8K
|
5
|
|
ASX - By Stock
|
ATH |
Presentation today
|
|
pierre77
|
19 |
8.2K |
2 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
19
|
8.2K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Proposed issue of Securities - ATH
|
|
pierre77
|
22 |
7.3K |
1 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
22
|
7.3K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Whats the Futur
|
|
pierre77
|
7 |
2.9K |
0 |
06/02/21 |
06/02/21 |
ASX - By Stock
|
7
|
2.9K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Sudden spike ! Up, up with high vol in NY
|
|
pierre77
|
17 |
5.9K |
3 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
17
|
5.9K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Sudden spike ! Up, up with high vol in NY
|
|
pierre77
|
17 |
5.9K |
2 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
17
|
5.9K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Sudden spike ! Up, up with high vol in NY
|
|
pierre77
|
17 |
5.9K |
3 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
17
|
5.9K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Sudden spike ! Up, up with high vol in NY
|
|
pierre77
|
17 |
5.9K |
4 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
17
|
5.9K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
us patent
|
|
pierre77
|
1 |
1.1K |
9 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
1
|
1.1K
|
9
|
|
ASX - By Stock
|
ATH |
Re:
CHART
|
|
pierre77
|
89 |
29K |
7 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
89
|
29K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
CHART
|
|
pierre77
|
89 |
29K |
9 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
89
|
29K
|
9
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity participates in JP Morgan healthcare conference
|
|
pierre77
|
5 |
3.3K |
3 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
5
|
3.3K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Antimicrobial resistance fund by over 20 big pharmas with $ 1B
|
|
pierre77
|
15 |
8.0K |
6 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
15
|
8.0K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New commercial opportunity for PBT2
|
|
pierre77
|
38 |
17K |
6 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
38
|
17K
|
6
|
|